The burden of smoking-related diseases in Brazil: Mortality, morbidity and costs;Estimativa da carga do tabagismo no Brasil: Mortalidade, morbidade e custos;Estimación de la carga de enfermedad atribuible al tabaquismo en Brasil: Mortalidad, morbilidad y costos

Cadernos de Saude Publica

Volumn 31, Issue 6, 2015, Pages 1283-1297

  Pinto, Márcia Teixeira ^a   Pichon Riviere, Andres ^b   Bardach, Ariel ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

Author keywords

Cost of illness; Mortality; Potential years of life lost; Smoking

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; BRAZIL; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED; COST OF ILLNESS; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; NEOPLASM; PREVALENCE; SMOKING; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CARDIOVASCULAR DISEASES; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORBIDITY; NEOPLASMS; PREVALENCE; SMOKING; STROKE;

EID: 84937422684     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/0102-311X00192013     Document Type: Article

References (49)

1. World Health Organization. Global status report on noncommunicable diseases 2010. Description of the global burden of NCDs, their risk factors and determinants. Geneva: World Health Organization; 2011.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-60.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
4. Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas. 3rd Ed. Atlanta: American Cancer Society; 2009.
5. U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress: a report of the surgeon general. Rockville: Office on Smoking and Health; 1989.
6. Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011; 377:139-46.
7. Lightwood J, Collins D, Lapsley H, Novotny TE. Estimating the costs of tobacco use. In: Jha P, Chaloupka F, editors. Tobacco control in developing countries. Oxford: Oxford University Press; 2000. p. 63-99.
8. World Bank. Curbing the epidemic: governments and the economics of tobacco control. Washington DC: World Bank; 1999.
9. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85:527-34.
10. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios: tabagismo 2008. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2009.
11. Menezes AM, Minten GC, Hallal PC, Victora CG, Horta BL, Gigante DP, et al. Tabagismo na coorte de nascimentos de 1982: da adolescência à vida adulta, Pelotas, RS. Rev Saúde Pública 2008; 42 Suppl 2:78-85.
12. Correa PC, Barreto SM, Passos VM. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health 2009; 9:206.
13. Levy D, Almeida LM, Szklo A. The Brazil SimSmoke policy simulation model: the effect of strong tobacco control policies on smoking prevalence and smoking-attributable deaths in a middle income nation. PLoS Med 2012; 9:e1001336.
14. Pinto M, Ugá MAD. Os custos de doenças tabaco-relacionadas para o Sistema Único de Saúde. Cad Saúde Pública 2011; 26:1234-45.
15. Pichon-Riviere A, Alcaraz A, Bardach A, Augustovski F, Caporale J, Caccavo F. Carga de enfermedad atribuible al tabaquismo en Argentina. Buenos Aires: Instituto de Efectividad Clínica y Sanitaria; 2013.
16. Pichon-Riviere A, Augustovski F, Bardach A, Co-lantonio L. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America. Value Health 2011; 14(5 Suppl 1):S51-9.
17. World Heath Organization. Systematic review of the link between tobacco and poverty. Geneva: World Heath Organization; 2011.
18. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 2003; 1:4.
19. Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 1999; 55:1137-44.
20. Lauer JA, Röhrich K, Wirth H, Charette C, Gribble S, Murray CJ. PopMod: a longitudinal population model with two interacting disease states. Cost Eff Resour Alloc 2003; 1:6.
21. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-6.
22. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97:72-81.
23. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v. 2.0, cancer incidence and mortality worldwide. Lyon: International Agency for Research on Cancer; 2010. (IARC CancerBase, 10).
24. Bray F, Ren S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132:1133-45.
25. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121(5 Suppl):121S-6S.
26. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117(5 Suppl 2):354S-9S.
27. Hoogendoorn M, Rutten-van Molken MP, Hoogenveen RT, van Genugten ML, Buist AS, Wouters EF, et al. A dynamic population model of disease progression in COPD. Eur Respir J 2005; 26:223-33.
28. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434-40.
29. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008; 57:1226-8.
30. Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–modeling studies. Value Health 2003; 6:9-17.
31. Ferrante D, Tajer CD. ¿Cuántos infartos hay en la Argentina? Rev Argent Cardiol 2007; 75:161-2.
32. Caccavo A, Álvarez A, Bello FH, Ferrari AE, Carrique AM, Lasdica A, et al. Incidencia poblacional del infarto con elevación del ST o bloqueo de rama izquierda a lo largo de 11 años en una comunidad de la provincia de Buenos Aires. Rev Argent Cardiol 2007; 75:185-8.
33. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994; 309:901-11.
34. Kirchhoff M, Davidsen M, Bronnum-Hansen H, Hansen B, Schnack H, Eriksen LS, et al. Incidence of myocardial infarction in the Danish MONICA population 1982-1991. Int J Epidemiol 1999; 28:211-8.
35. Menezes AM, Pérez-Padilla R, Jardim JR, Muino A, López MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366:1875-81.
36. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1995; 26:361-7.
37. Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001; 16:326-31.
38. Departamento de Tecnologia e Insumos Estratégicos, Secretaria de Ciência e Tecnologia, Ministério da Saúde. Diretrizes metodológicas: estudos de avaliação econômica de tecnologias em saúde. Brasília: Ministério da Saúde; 2009.
39. Azambuja MI, Foppa M, Maranhão MF, Achutti AC. Economic burden of severe cardiovascular diseases in Brazil: an estimate based on secondary data. Arq Bras Cardiol 2008; 91:148-55.
40. Presidência da República. Decreto no 5.658, de 2 de janeiro de 2006. Promulga a Convenção-Quadro sobre Controle do Uso do Tabaco, adotada pelos países membros da Organização Mundial de Saúde em 21 de maio de 2003 e assinada pelo Brasil em 16 de junho de 2003. Diário Oficial da União 2006; 3 jan.
41. Costa AJL, Figueiredo VC, Cavalcante T, Noronha C, Colombo V, Almeida L. Mortalidade atribuível ao tabagismo passivo na população urbana do Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2008.
42. Max W, Sung HY, Shi Y. Deaths from secondhand smoke exposure in the United States: economic implications. Am J Public Health 2012; 102:2173-80.
43. McGhee SM, Ho LM, Lapsley HM, Chau J, Cheung WL, Ho SY, et al. Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control 2006; 15:125-30.
44. Pinto M, Ugá MA. Cost of treating patients with smoking history in a specialized cancer hospital. Rev Saúde Pública 2011; 45:575-82.
45. John RM, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control 2009; 18: 138-43.
46. Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control 2006; 15:464-71.
47. Yang L, Sung HY, Mao Z, Hu TW, Rao K. Economic costs attributable to smoking in China: update and an 8-year comparison, 2000-2008. Tob Control 2011; 20:266-72.
48. Secretaria da Receita Federal do Brasil, Ministério da Fazenda. Arrecadação de tributos federais setor de fabricação de cigarros. http://www.receita.fazenda.gov.br/DestinacaoMercadorias/ProgramaNacCombCigarroIlegal/ArrecadacaoCigarros/ArrecCigarro20132014.htm (accessed on 10/Jun/2013).
49. Jiménez-Corona A, López-Ridaura R, González-Villalpando C. Incidence of myocardial infarction in low-income urban residents of Mexico City. Incidencia de infarto al miocardio en residentes de nivel socioeconómico bajo de la Ciudad de México. Salud Pública Méx 2009; 51:458-64.